-+ 0.00%
-+ 0.00%
-+ 0.00%

RA Capital Management reports sale of $9.13 million in Lenz Therapeutics common shares

PUBT·11/02/2026 22:45:19
Listen to the news
RA Capital Management reports sale of $9.13 million in Lenz Therapeutics common shares
  • RA Capital Management reported selling 2,718,684 Lenz Therapeutics common shares on Oct. 29, 2026.
  • The reported sale price was $3.36 per share.
  • Indirect beneficial holdings totaled 1,460,139 shares following the transactions, according to the Form 4 signed Nov. 2, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lenz Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-001526), on November 02, 2026, and is solely responsible for the information contained therein.